BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12890197)

  • 1. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.
    Pföhler C; Haus A; Palmowski A; Ugurel S; Ruprecht KW; Thirkill CE; Tilgen W; Reinhold U
    Br J Dermatol; 2003 Jul; 149(1):74-8. PubMed ID: 12890197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
    Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
    Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe course of cutaneous melanoma associated paraneoplastic retinopathy.
    Kellner U; Bornfeld N; Foerster MH
    Br J Ophthalmol; 1995 Aug; 79(8):746-52. PubMed ID: 7547786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature.
    Boeck K; Hofmann S; Klopfer M; Ian U; Schmidt T; Engst R; Thirkill CE; Ring J
    Br J Dermatol; 1997 Sep; 137(3):457-60. PubMed ID: 9349350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Melanoma-associated retinopathy. Apropos of a case and review of the literature].
    Bret-Dibat C; Rougier MB; Le Rebeller MJ; Delaunay M
    Bull Cancer; 1996 Dec; 83(12):1019-22. PubMed ID: 9116366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Node way out.
    Vaphiades MS; Brown H; Whitcup SM
    Surv Ophthalmol; 2000; 45(1):77-83. PubMed ID: 10946083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral manifestation of melanoma-associated retinopathy.
    Janáky M; Pálffy A; Kolozsvári L; Benedek G
    Arch Ophthalmol; 2002 Jun; 120(6):866-7. PubMed ID: 12049605
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
    Karatsai E; Robson AG; Taylor SRJ
    JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
    Keltner JL; Thirkill CE; Yip PT
    J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid treatment for melanoma-associated retinopathy: effect on visual acuity and electrophysiologic findings.
    Jacobzone C; Cochard-Marianowski C; Kupfer I; Bettembourg S; Dordain Y; Misery L; Cochener B; Sassolas B
    Arch Dermatol; 2004 Oct; 140(10):1258-61. PubMed ID: 15492190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous melanoma-associated retinopathy with retinal periphlebitis.
    Remulla JF; Pineda R; Gaudio AR; Milam AH
    Arch Ophthalmol; 1995 Jul; 113(7):854-5. PubMed ID: 7605271
    [No Abstract]   [Full Text] [Related]  

  • 12. [Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
    Rougier MB; Hostyn P; Bret-Dibat C; Delaunay MM; Riss I; Le Rebeller MJ
    J Fr Ophtalmol; 1995; 18(5):396-403. PubMed ID: 7560778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer-associated retinopathy].
    Ohguro H; Takaya T; Ogawa K; Suzuki J; Nakagawa T
    Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):283-7. PubMed ID: 9136565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
    Potter MJ; Adamus G; Szabo SM; Lee R; Mohaseb K; Behn D
    Am J Ophthalmol; 2002 Jul; 134(1):128-30. PubMed ID: 12095824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic night blindness with malignant melanoma.
    Berson EL; Lessell S
    Am J Ophthalmol; 1988 Sep; 106(3):307-11. PubMed ID: 2971322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
    Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
    Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma-associated retinopathy versus abnormal retinal function due to interferon-alpha/Isotretinoin therapy in cutaneous malignant melanoma.
    Feigl B; Faschinger C; Soyer P
    Ophthalmologica; 2000; 214(4):271-6. PubMed ID: 10859510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal findings in melanoma-associated retinopathy.
    Borkowski LM; Grover S; Fishman GA; Jampol LM
    Am J Ophthalmol; 2001 Aug; 132(2):273-5. PubMed ID: 11476700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site.
    Kiratli H; Thirkill CE; Bilgiç S; Eldem B; Keçeci A
    Eye (Lond); 1997; 11 ( Pt 6)():889-92. PubMed ID: 9537153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanoma-associated retinopathy.
    Kim RY; Retsas S; Fitzke FW; Arden GB; Bird AC
    Ophthalmology; 1994 Nov; 101(11):1837-43. PubMed ID: 7800366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.